Nachrichten

Was ist neu?

Lesen Sie alle Neuigkeiten zum AGE Reader, Diab-Spot und DiagnOptics.

AGE Reader approved as medical device in Mexico

The AGE Reader has received its market approval from COFEPRIS in Mexico. “We have been working on
this for a long time with our partner PDE in Mexico, says Bart van den Berg, CEO of Diagnoptics.
Perseverance was needed because the severe hit by Covid caused a significant delay.” PDE, or
Prevención Y Detección Especializada, is specialized in early detection of disease like breast cancer,
cardiovascular disease and diabetes. The availability of the AGE Reader in Mexico will certainly improve
the prevention from these devastating diseases. The introduction of the AGE Reader and education of
the medical society has already started, so people in Mexico may expect the opportunity to be checked
on their health risks soon.

The AGE Reader provides an immediate cardiovascular risk prediction in 12 Seconds. It has been
designed for patient friendly diagnosis and allows doctors to practice personalized care and prevent
disease (progression). As an optical measurement of the skin is used, it is noninvasive and provides an
alternative to cost-intensive laboratory tests. The method is convenient, easy to use and extensively
validated.

If you would like to receive further information regarding the AGE Reader, please do not hesitate to
contact us. If you are based in Mexico, please contact PDE directly on contact PDE.

Share this link on:

Latest news items

Weitere Informationen
INFORMATIONSANFRAGE

Möchten Sie mehr über unsere Produkte erfahren? Fordern Sie alle Informationen an, die Sie hier erhalten möchten.

AGE Reader mu
Nichtinvasive kardiovaskuläre Risikobewertung
Age Reader MU
Der AGE Reader mu ist der AGE Reader der nächsten Generation, der einen hohen Messstandard mit einem innovativen Design und einem reduzierten Preisniveau verbindet. Der AGE Reader mu ist das perfekte Hilfsmittel für Diabetologen und Hausärzte. Mehr »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

Über das Unternehmen

Informationen über Diagnoptics.

Patienteninformationen

Informationen über Produkte von Diagnoptics und Advanced Glycation Endproducts.

Informationen für Fachleute

Informatie over geavanceerde glycatie eindproducten, AGE meting en klinische validatie